{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T22:41:49Z","timestamp":1708555309494},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s00106-019-0719-2","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T16:03:14Z","timestamp":1565625794000},"page":"715-730","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immundefekte bei chronischer Rhinosinusitis","Immunodeficiency in chronic rhinosinusitis"],"prefix":"10.1007","volume":"67","author":[{"given":"L.","family":"Klimek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sperl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Koennecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Eckrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"719_CR1","doi-asserted-by":"publisher","DOI":"10.4193\/rhino50e2","author":"WJ Fokkens","year":"2012","unstructured":"Fokkens\u00a0WJ, Lund\u00a0VJ, al Mullol Jet (2012) European position paper on rhinosinusitis and nasal polyps 2012. Rhinology. https:\/\/doi.org\/10.4193\/rhino50e2","journal-title":"Rhinology"},{"key":"719_CR2","first-page":"1216","volume":"66","author":"D Hastan","year":"2011","unstructured":"Hastan\u00a0D, Fokkens\u00a0WJ, al Bachert Cet (2011) Chronic rhinosinusitis in Europe\u2014an underestimated disease. A GA(2)LEN study. Arerugi 66:1216\u20131223","journal-title":"Arerugi"},{"key":"719_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00106-017-0401-5","volume":"66","author":"BA Stuck","year":"2018","unstructured":"Stuck\u00a0BA, Beule\u00a0A, Jobst\u00a0D et al (2018) Guideline for \u201crhinosinusitis\u201d-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery. HNO 66:38\u201374","journal-title":"HNO"},{"key":"719_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.otohns.2007.07.021","volume":"137","author":"RM Rosenfeld","year":"2007","unstructured":"Rosenfeld\u00a0RM (2007) Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg 137:365\u2013377","journal-title":"Otolaryngol Head Neck Surg"},{"key":"719_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s40629-017-0048-5","volume":"27","author":"M Koennecke","year":"2018","unstructured":"Koennecke\u00a0M, Klimek\u00a0L, Mullol\u00a0J, Gevaert\u00a0P, Wollenberg\u00a0B (2018) Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities. Allergo J Int 27:56\u201365","journal-title":"Allergo J Int"},{"key":"719_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11882-018-0776-8","volume":"18","author":"K Avdeeva","year":"2018","unstructured":"Avdeeva\u00a0K, Fokkens\u00a0W (2018) Precision medicine in chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep 18:25","journal-title":"Curr Allergy Asthma Rep"},{"key":"719_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13601-017-0157-8","volume":"7","author":"G De Greve","year":"2017","unstructured":"De Greve\u00a0G, Hellings\u00a0PW, Fokkens\u00a0WJ, Pugin\u00a0B, Steelant\u00a0B, Seys\u00a0SF (2017) Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy 7:22","journal-title":"Clin Transl Allergy"},{"key":"719_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","volume":"137","author":"P Tomassen","year":"2016","unstructured":"Tomassen\u00a0P, Vandeplas\u00a0G, Van Zele\u00a0T (2016) Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J\u00a0Allergy Clin Immunol 137:1449\u20131456.e4","journal-title":"J Allergy Clin Immunol"},{"key":"719_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-019-0683-x","author":"P Ickrath","year":"2019","unstructured":"Ickrath\u00a0P, Morbach\u00a0H, Schwaneck\u00a0EC, Gehrke\u00a0T, Scherzad\u00a0A, Hagen\u00a0R, Hackenberg\u00a0S (2019) Recurrent infections in patients with primary immunodeficiency. HNO. https:\/\/doi.org\/10.1007\/s00106-019-0683-x","journal-title":"HNO"},{"key":"719_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"FA Bonilla","year":"2015","unstructured":"Bonilla\u00a0FA, Khan\u00a0DA, Ballas\u00a0ZK et al (2015) Practice parameter for the diagnosis and management of primary immunodeficiency. J\u00a0Allergy Clin Immunol 136:1186\u2013205.e1-78. https:\/\/doi.org\/10.1016\/j.jaci.2015.04.049","journal-title":"J Allergy Clin Immunol"},{"key":"719_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/ar2843","volume":"11","author":"F Annunziato","year":"2009","unstructured":"Annunziato\u00a0F, Romagnani\u00a0S (2009) Heterogeneity of human effector CD4+ T cells. Arthritis Res Ther 11:257","journal-title":"Arthritis Res Ther"},{"key":"719_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/B978-0-12-387664-5.00005-4","volume":"109","author":"B Zygmunt","year":"2011","unstructured":"Zygmunt\u00a0B, Veldhoen\u00a0M (2011) T helper cell differentiation more than just cytokines. Adv Immunol 109:159\u2013196","journal-title":"Adv Immunol"},{"key":"719_CR13","first-page":"1280","volume":"61","author":"T Van Zele","year":"2006","unstructured":"Van Zele\u00a0T, Claeys\u00a0S, Gevaert\u00a0P et\u00a0al (2006) Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Arerugi 61:1280\u20131289","journal-title":"Arerugi"},{"key":"719_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jaci.2015.07.016","volume":"136","author":"AJ Schwitzguebel","year":"2015","unstructured":"Schwitzguebel\u00a0AJ, Jandus\u00a0P, Lacroix\u00a0JS, Seebach\u00a0JD, Harr\u00a0T (2015) Immunoglobulin deficiency in patients with chronic rhinosinusitis: systematic review of the literature and meta-analysis. J\u00a0Allergy Clin Immunol 136:1523\u20131531","journal-title":"J Allergy Clin Immunol"},{"key":"719_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2500\/ajra.2010.24.3532","volume":"24","author":"M Alqudah","year":"2010","unstructured":"Alqudah\u00a0M, Graham\u00a0SM, Ballas\u00a0ZK (2010) High prevalence of humoral immunodeficiency patients with refractory chronic rhinosinusitis. Am J Rhinol Allergy 24:409\u2013412","journal-title":"Am J Rhinol Allergy"},{"key":"719_CR16","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1007\/s00405-016-3981-x","volume":"273","author":"H Odat","year":"2016","unstructured":"Odat\u00a0H, Alqudah\u00a0M (2016) Prevalence and pattern of humoral immunodeficiency in chronic refractory sinusitis. Eur Arch Otorhinolaryngol 273:3189\u20133193","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"719_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11882-010-0098-y","volume":"10","author":"MW Ryan","year":"2010","unstructured":"Ryan\u00a0MW, Brooks\u00a0EG (2010) Rhinosinusitis and comorbidities. Curr Allergy Asthma Rep 10:188\u2013193","journal-title":"Curr Allergy Asthma Rep"},{"key":"719_CR18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1586\/14787210.2013.839380","volume":"11","author":"M Mahdavinia","year":"2013","unstructured":"Mahdavinia\u00a0M, Grammer\u00a0LC 3rd (2013) Chronic rhinosinusitis and age: is the pathogenesis different? Expert Rev Anti Infect Ther 11:1029\u20131040","journal-title":"Expert Rev Anti Infect Ther"},{"key":"719_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley\u00a0ME, Notarangelo\u00a0LD, Etzioni\u00a0A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93:190\u2013197","journal-title":"Clin Immunol"},{"key":"719_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla\u00a0FA, Barlan\u00a0I, Chapel H\u00a0H et\u00a0al (2016) International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J\u00a0Allergy Clin Immunol Pract 4:38\u201359","journal-title":"J Allergy Clin Immunol Pract"},{"key":"719_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2500\/ajra.2013.27.3855","volume":"27","author":"RC Agondi","year":"2013","unstructured":"Agondi\u00a0RC, Barros\u00a0MT, Kokron\u00a0CM et\u00a0al (2013) Can patients with common variable immunodeficiency have allergic rhinitis? Am J Rhinol Allergy 27:79\u201383","journal-title":"Am J Rhinol Allergy"},{"key":"719_CR22","first-page":"41","volume":"56","author":"C Ozcan","year":"2014","unstructured":"Ozcan\u00a0C, Metin\u00a0A, Erkocoglu\u00a0M, Kocabas\u00a0CN (2014) Allergic diseases in children with primary immunodeficiencies. Turk J Pediatr 56:41\u201347","journal-title":"Turk J Pediatr"},{"key":"719_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1586\/1744666X.2016.1126509","volume":"12","author":"R Ameratunga","year":"2016","unstructured":"Ameratunga\u00a0R, Storey\u00a0P, Barker\u00a0R, Jordan\u00a0A, Koopmans\u00a0W, Woon\u00a0ST (2016) Application of diagnostic and treatment criteria for common variable immunodeficiency disorder. Expert Rev Clin Immunol 12:257\u2013266","journal-title":"Expert Rev Clin Immunol"},{"key":"719_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","volume":"5","author":"R Ameratunga","year":"2014","unstructured":"Ameratunga\u00a0R, Brewerton\u00a0M, Slade\u00a0C et\u00a0al (2014) Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol 5:415","journal-title":"Front Immunol"},{"key":"719_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1586\/1744666X.2014.870478","volume":"10","author":"M Seppanen","year":"2014","unstructured":"Seppanen\u00a0M, Aghamohammadi\u00a0A, Rezaei\u00a0N (2014) Is there a\u00a0need to redefine the diagnostic criteria for common variable immunodeficiency? Expert Rev Clin Immunol 10:1\u20135","journal-title":"Expert Rev Clin Immunol"},{"key":"719_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann\u00a0B, Mahlaoui\u00a0N, CEREDIH et\u00a0al (2014) Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J\u00a0Allergy Clin Immunol 134:116\u2013126","journal-title":"J Allergy Clin Immunol"},{"key":"719_CR27","unstructured":"European Society for Immunodeficiencies (ESID). Available at: https:\/\/esid.org . \u00a9\u00a02019 by European Society for Immunodeficiencies (ESID). All rights reserved. Designed by ZWEBB|powered by eZ Publish\u2122"},{"key":"719_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1615\/CritRevImmunol.v31.i2.10","volume":"31","author":"AAJM van de Ven","year":"2011","unstructured":"van de Ven\u00a0AAJM, Compeer\u00a0EB, van Montfrans\u00a0JM, Boes\u00a0M (2011) B\u2011cell defects in common variable immunodeficiency: BCR signaling, protein clustering and hardwired gene mutations. Crit Rev Immunol 31:85\u201398","journal-title":"Crit Rev Immunol"},{"key":"719_CR29","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick\u00a0ES, Moshier\u00a0EL, Godbold\u00a0JH, Cunningham-Rundles\u00a0C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119:1650\u20131657","journal-title":"Blood"},{"key":"719_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.29262\/ram.v62i1.55","volume":"62","author":"G Angulo-Perez","year":"2015","unstructured":"Angulo-Perez\u00a0G, Vivar-Acevedo\u00a0E, Vargas-Aguayo\u00a0A, Lopez-Rocha\u00a0E (2015) Prevalence, location and tomographic severity of chronic rhinosinusitis in adult patients with common variable immunodeficiency. Rev Alerg Mex 62:15\u201321","journal-title":"Rev Alerg Mex"},{"key":"719_CR31","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","volume":"130","author":"JS Orange","year":"2012","unstructured":"Orange\u00a0JS, Ballow\u00a0M, Stiehm\u00a0ER et\u00a0al (2012) Use and interpretation of diagnostic vaccination in primary immunodeficiency: a\u00a0working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J\u00a0Allergy Clin Immunol 130:S1\u2013S24","journal-title":"J Allergy Clin Immunol"},{"key":"719_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2500\/ajra.2011.25.3653","volume":"25","author":"TF Carr","year":"2011","unstructured":"Carr\u00a0TF, Koterba\u00a0AP, Chandra\u00a0R et\u00a0al (2011) Characterization of specific antibody deficiency in adults with medically refractory chronic rhinosinusitis. Am J Rhinol Allergy 25:241\u2013244","journal-title":"Am J Rhinol Allergy"},{"key":"719_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaip.2014.09.022","volume":"3","author":"S Kashani","year":"2015","unstructured":"Kashani\u00a0S, Carr\u00a0TF, Grammer\u00a0LC et\u00a0al (2015) Clinical characteristics of adults with chronic rhinosinusitis and specific antibody deficiency. J\u00a0Allergy Clin Immunol Pract 3:236\u2013242","journal-title":"J Allergy Clin Immunol Pract"},{"key":"719_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01131.x","volume":"120","author":"L Hammarstrom","year":"2000","unstructured":"Hammarstrom\u00a0L, Vorechovsky\u00a0I, Webster\u00a0D (2000) Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225\u2013231","journal-title":"Clin Exp Immunol"},{"key":"719_CR35","first-page":"1589","volume":"68","author":"C Hupin","year":"2013","unstructured":"Hupin\u00a0C, Rombaux\u00a0P, Bowen\u00a0H, Gould\u00a0H, Lecocq\u00a0M, Pilette\u00a0C (2013) Downregulation of polymeric immunoglobulin receptor and secretory IgA antibodies in eosinophilic upper airway diseases. Arerugi 68:1589\u20131597","journal-title":"Arerugi"},{"key":"719_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2500\/ajra.2013.27.3831","volume":"27","author":"CJ Ocampo","year":"2013","unstructured":"Ocampo\u00a0CJ, Peters\u00a0AT (2013) Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illness. Am J Rhinol Allergy 27:34\u201338","journal-title":"Am J Rhinol Allergy"},{"key":"719_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/alr.21174","volume":"3","author":"S Alromaih","year":"2013","unstructured":"Alromaih\u00a0S, Mfuna-Endam\u00a0L, Bosse\u00a0Y, Filali-Mouhim\u00a0A, Desrosiers\u00a0M (2013) CD8A gene polymorphisms predict severity factors in chronic rhinosinusitis. Int Forum Allergy Rhinol 3:605\u2013611","journal-title":"Int Forum Allergy Rhinol"},{"key":"719_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/alr.21313","volume":"4","author":"N Gabra","year":"2014","unstructured":"Gabra\u00a0N, Alromaih\u00a0S, Endam\u00a0LM et al (2014) Clinical features of cytotoxic CD8+ T\u2011lymphocyte deficiency in chronic rhinosinusitis patients: a\u00a0demographic and functional study. Int Forum Allergy Rhinol 4:495\u2013501","journal-title":"Int Forum Allergy Rhinol"},{"key":"719_CR39","volume-title":"Patient & family handbook for primary Immunodeficiency diseases","author":"RM Blaese","year":"2013","unstructured":"Blaese\u00a0RM, Bonilla\u00a0FA, Stiehm\u00a0ER, Younger\u00a0ME (2013) Patient & family handbook for primary Immunodeficiency diseases, 5.\u00a0Aufl. Immune Deficiency Foundation, Towson","edition":"5"},{"key":"719_CR40","first-page":"128","volume":"112","author":"A Kleger","year":"2015","unstructured":"Kleger\u00a0A, Seufferlein\u00a0T, Wagner\u00a0M, Tannapfel\u00a0A, Hoffmann\u00a0TK, Mayerle\u00a0J (2015) IgG4-related autoimmune diseases: polymorphous presentation complicates diagnosis and treatment. Dtsch Arztebl Int 112:128\u2013135","journal-title":"Dtsch Arztebl Int"},{"key":"719_CR41","doi-asserted-by":"publisher","first-page":"e100324","DOI":"10.1371\/journal.pone.0100324","volume":"9","author":"SS Duraisingham","year":"2014","unstructured":"Duraisingham\u00a0SS, Buckland\u00a0M, Dempster\u00a0J, Lorenzo\u00a0L, Grigoriadou\u00a0S, Longhurst\u00a0HJ (2014) Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement. PLoS ONE 9:e100324","journal-title":"PLoS ONE"},{"key":"719_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2014.11.009","volume":"57","author":"DM Roberts","year":"2015","unstructured":"Roberts\u00a0DM, Jones\u00a0RB, Smith\u00a0RM et al (2015) Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease. J\u00a0Autoimmun 57:60\u201365","journal-title":"J Autoimmun"},{"key":"719_CR43","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jaci.2015.06.035","volume":"136","author":"S Barmettler","year":"2015","unstructured":"Barmettler\u00a0S, Price\u00a0C (2015) Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab\u2014for how long? J\u00a0Allergy Clin Immunol 136:1407\u20131409","journal-title":"J Allergy Clin Immunol"},{"key":"719_CR44","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1097\/TP.0000000000000114","volume":"97","author":"A Gujadhur","year":"2014","unstructured":"Gujadhur\u00a0A, Thomson\u00a0N, Aung\u00a0AK, McLean\u00a0C, Menahem\u00a0S (2014) CMV sinusitis in a\u00a0HIV-negative renal transplant recipient. Transplantation 97:e55\u201357","journal-title":"Transplantation"},{"key":"719_CR45","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.4081\/idr.2012.e9","volume":"4","author":"E Iacovou","year":"2012","unstructured":"Iacovou\u00a0E, Vlastarakos\u00a0PV, Papacharalampous\u00a0G, Kampessis\u00a0G, Nikolopoulos\u00a0TP (2012) Diagnosis and treatment of HIV-associated manifestations in otolaryngology. Infect Dis Rep 4:e9","journal-title":"Infect Dis Rep"},{"key":"719_CR46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1590\/S1808-86942011000300020","volume":"77","author":"FA Sanjar","year":"2011","unstructured":"Sanjar\u00a0FA, Queiroz\u00a0BE, Miziara\u00a0ID (2011) Otolaryngologic manifestations in HIV disease\u2014clinical aspects and treatment. Braz J Otorhinolaryngol 77:391\u2013400","journal-title":"Braz J Otorhinolaryngol"},{"key":"719_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/1744666X.2016.1216790","volume":"13","author":"SE Chiarella","year":"2017","unstructured":"Chiarella\u00a0SE, Grammer\u00a0LC (2017) Immune deficiency in chronic rhinosinusitis: screening and treatment. Expert Rev Clin Immunol 13:117\u2013123","journal-title":"Expert Rev Clin Immunol"},{"key":"719_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jclinpath-2014-202618","volume":"68","author":"PD Bright","year":"2015","unstructured":"Bright\u00a0PD, Rooney\u00a0N, Virgo\u00a0PF, Lock\u00a0RJ, Johnston\u00a0SL, Unsworth\u00a0DJ (2015) Laboratory clues to immunodeficiency; missed chances for early diagnosis? J\u00a0Clin Pathol 68:1\u20135","journal-title":"J Clin Pathol"},{"key":"719_CR49","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.anai.2014.07.025","volume":"113","author":"AT Peters","year":"2014","unstructured":"Peters\u00a0AT, Spector\u00a0S, Hsu J\u00a0J et\u00a0al (2014) Diagnosis and management of rhinosinusitis: a\u00a0practice parameter update. Ann Allergy Asthma Immunol 113:347\u2013385","journal-title":"Ann Allergy Asthma Immunol"},{"key":"719_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/MOO.0b013e32835ac625","volume":"21","author":"RT Adelson","year":"2013","unstructured":"Adelson\u00a0RT, Adappa\u00a0ND (2013) What is the proper role of oral antibiotics in the treatment of patients with chronic sinusitis? Curr Opin Otolaryngol Head Neck Surg 21:61\u201368","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"719_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MOO.0000000000000022","volume":"22","author":"PT Russell","year":"2014","unstructured":"Russell\u00a0PT, Bekeny\u00a0JR (2014) Oral antibiotics and the management of chronic sinusitis: what do we know? Curr Opin Otolaryngol Head Neck Surg 22:22\u201326","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"719_CR52","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/ACI.0b013e32835914b9","volume":"12","author":"ES Resnick","year":"2012","unstructured":"Resnick\u00a0ES, Cunningham-Rundles\u00a0C (2012) The many faces of the clinical picture of common variable immune deficiency. Curr Opin Allergy Clin Immunol 12:595\u2013601","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"719_CR53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2500\/ajra.2010.24.3464","volume":"24","author":"AN Khalid","year":"2010","unstructured":"Khalid\u00a0AN, Mace\u00a0JC, Smith\u00a0TL (2010) Outcomes of sinus surgery in ambulatory patients with immune dysfunction. Am J Rhinol Allergy 24:230\u2013233","journal-title":"Am J Rhinol Allergy"},{"key":"719_CR54","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/lary.25305","volume":"125","author":"AM Dao","year":"2015","unstructured":"Dao\u00a0AM, Rereddy\u00a0SK, Wise\u00a0SK, DelGaudio\u00a0JM, Patel\u00a0ZM (2015) Management of non-invasive rhinosinusitis in the immunosuppressed patient population. Laryngoscope 125:1767\u20131771","journal-title":"Laryngoscope"},{"key":"719_CR55","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.2500\/ar.2013.4.0070","volume":"4","author":"ZM Patel","year":"2013","unstructured":"Patel\u00a0ZM (2013) Practice patterns regarding noninvasive rhinosinusitis in the immunosuppressed patient population. Allergy Rhinol (providence) 4:e151\u2013e154","journal-title":"Allergy Rhinol (providence)"},{"issue":"Suppl 1","key":"719_CR56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s10875-016-0267-4","volume":"36","author":"VC Rodriguez-Cortez","year":"2016","unstructured":"Rodriguez-Cortez\u00a0VC, Del Pino-Molina\u00a0L, Rodriguez-Ubreva\u00a0J, Lopez-Granados\u00a0E, Ballestar\u00a0E (2016) Dissecting epigenetic dysregulation of primary antibody deficiencies. J\u00a0Clin Immunol 36(Suppl 1):48\u201356","journal-title":"J Clin Immunol"},{"key":"719_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1165\/rcmb.2014-0486OC","volume":"54","author":"KN Cahill","year":"2016","unstructured":"Cahill\u00a0KN, Raby\u00a0BA, Zhou\u00a0X et al (2016) Impaired E Prostanoid2 expression and resistance to prostaglandin E2 in nasal polyp fibroblasts from subjects with aspirin-exacerbated respiratory disease. Am J Respir Cell Mol Biol 54:34\u201340","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-019-0719-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-019-0719-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-019-0719-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T01:05:53Z","timestamp":1695085553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-019-0719-2"}},"subtitle":["Eine bedeutende und oft untersch\u00e4tzte Ursache","An important and often underestimated cause"],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1007\/s00106-019-0719-2","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"12 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>L.\u00a0Klimek<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: \u00c4rztlicher Leiter des Zentrums f\u00fcr Rhinologie und Allergologie, Wiesbaden | Mitgliedschaften und Position in wissenschaftlichen Gesellschaften\/Berufsverb\u00e4nden und ggf. anderen, f\u00fcr diese Fortbildungsma\u00dfnahme relevanten Vereinigungen: Pr\u00e4sident des \u00c4rzteverbandes Deutscher Allergologen, Pr\u00e4sident der Deutschen AllergieLiga, Vizepr\u00e4sident der Deutschen Akademie f\u00fcr Allergologie und Umweltmedizin, Section Chair ENT der European Academy for Allergology and Clinical Immunology, Vorstandsmitglied der AG Allergologie der DGHNOKHC.<b>A.\u00a0Chaker<\/b>: Finanzielle Interessen: European Institute of Technology (EU): Forschungsf\u00f6rderung, Deutsches Zentrum Lungenforschung (DZL\/BMBF): Forschungsf\u00f6rderung, Thermo Fisher (Schweden): Drittmittelprojekt, ALK Abell\u00f3 (D\u00e4nemark): klinische Studien, ASIT Biotech (Belgien): klinische Studien, Allergopharma\/Merck (Deutschland): Drittmittelprojekte und klinische Studien, Bencard\/Allergen Therapeutics (Deutschland\/UK): klinische Studien, GSK (UK): klinische Studien, LETI (Spanien): Drittmittelprojekt, Roche (Schweiz): klinische Studie, Zeller (Schweiz): Drittmittelprojekt \u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer (Teilnahmegeb\u00fchren, Reise\u2011\/\u00dcbernachtungskosten): Honorare f\u00fcr Vortr\u00e4ge oder Advisory Boards via TUM Medical School, Technische Universit\u00e4t M\u00fcnchen: ALK Abell\u00f3 (D\u00e4nemark), Allergopharma\/Merck (Deutschland), Astra Zeneca (Deutschland\/UK), Sanofi Genzyme (Deutschland\/USA) | Honorare f\u00fcr Vortr\u00e4ge, wissenschaftliche Artikel oder andere Aktivit\u00e4ten f\u00fcr wissenschaftliche Fachgesellschaften oder berufsst\u00e4ndische Organisationen: Bayerische Landes\u00e4rztekammer, Bayerische Landesapothekenkammer, Europ\u00e4ische Allergiegesellschaft (EAACI), Deutsche Gesellschaft f\u00fcr Pneumologie, Deutsche Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Hals-Chirurgie \u2013 bezahlter Berater, interner Schulungsreferent oder Bezug eines Gehalts o.\u202f\u00c4.: Honorare f\u00fcr Vortr\u00e4ge oder Advisory Boards via TUM Medical School, Technische Universit\u00e4t M\u00fcnchen: ALK Abell\u00f3 (D\u00e4nemark), Allergopharma\/Merck (Deutschland), Astra Zeneca (Deutschland\/UK), Sanofi Genzyme (Deutschland\/USA) | Honorare f\u00fcr Vortr\u00e4ge, wissenschaftliche Artikel oder andere Aktivit\u00e4ten f\u00fcr wissenschaftliche Fachgesellschaften oder berufsst\u00e4ndische Organisationen: Bayerische Landes\u00e4rztekammer, Bayerische Landesapothekenkammer, Europ\u00e4ische Allergiegesellschaft (EAACI), Deutsche Gesellschaft f\u00fcr Pneumologie, Deutsche Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Hals-Chirurgie \u2013 Patent: HNA ratio of immune cells as prognostic indicator of therapeutic success in allergen-specific immunotherapy: 17 177 681.8. Nichtfinanzielle Interessen: HNO-Facharzt und Allergologe, Oberarzt am Klinikum rechts der Isar und Arbeitsgruppenleiter am Zentrum f\u00fcr Allergie und Umwelt (TU M\u00fcnchen) | Mitgliedschaften: Interest Group Allergen Immunotherapy der Europ\u00e4ischen Allergiegesellschaft (EAACI), Sprecher des Vorstands der Arbeitsgemeinschaft Allergologie und klinische Immunologie der deutschen HNO-Gesellschaft.<b>C.\u00a0Matthias<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Chefarzt am Universit\u00e4tsmedizin der Johannes-Gutenberg-Universit\u00e4t Mainz | Direktor der Hals-Nasen-Ohrenklinik.<b>A.\u00a0Sperl<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: angestellte HNO-\u00c4rztin, Zentrum f\u00fcr Rhinologie und Allergologie, Prof. Dr. L. Klimek, Wiesbaden.<b>P.\u00a0Gevaert<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Chairman and Head of the Department of Otorhinolaryngology of the University of Ghent, Belgium, former Chair of the ENT section of the European Academy of Allergy and Clinical Immunology | Memberships: European Forum for Research and Education in Allergy and Airways disease (EUFOREA), European Rhinologic Society (ERS).<b>P.\u00a0Hellings<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Clinic Head and Full Professor at the University Hospital of Leuven (Belgium) and Professor at the Universities of Amsterdam and Ghent, Secretary-General of the European Academy of Allergy and Clinical Immunology | Founding Director of the European Forum for Research and Education in Allergy and Airways disease (EUFOREA) | Course director and founder of: European Rhinoplasty Course in Brussels, International Course in Modern Rhinoplasty Techniques in Amsterdam.<b>B.\u00a0Wollenberg<\/b>: Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer (Teilnahmegeb\u00fchren, Reise\u2011\/\u00dcbernachtungskosten): Sanofi, 2018, ca. 1200\u202f\u20ac. Nichtfinanzielle Interessen: Direktorin der Klinik f\u00fcr Hals\u2011, Nasen- und Ohrenheilkunde am Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck.<b>M.\u00a0Koennecke<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: wissenschaftlicher Mitarbeiter, HNO, UKSH L\u00fcbeck.<b>J.\u00a0Hagemann<\/b>: Finanzielle Interessen: M\u00fcnchener Universit\u00e4tsgesellschaft. Nichtfinanzielle Interessen: angestellter Assistenzarzt, Hals\u2011, Nasen\u2011, Ohrenklinik und Poliklinik \u2013 Plastische Operationen, Universit\u00e4tsmedizin Mainz | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Hals-Nasen-Ohrenheilkunde, European Rhinologic Society, American Academy of Otolaryngology\/Head and Neck Surgery, Amercian College of Surgeons.<b>J.\u00a0Eckrich<\/b>: Finanzielle Interessen: 2017: Stiftung Tumorforschung Kopf-Hals 15.000\u202f\u20ac, Anschubf\u00f6rderung f\u00fcr das Projekt \u201eTumore in statischen Magnetfeldern\u201c | 2018: Universit\u00e4tsinterne F\u00f6rderung TransMed im Rahmen des Clinican Scientist Programms TV\u00c4, A1 50\u202f% f\u00fcr 2\u00a0Jahre zzgl. 10.000\u202f\u20ac Sachmittel. Nichtfinanzielle Interessen: angestellter wissenschaftlicher Mitarbeiter (Assistenzarzt), Hals\u2011, Nasen\u2011, Ohrenklinik und Poliklinik \u2013 Plastische Operationen, Universit\u00e4tsmedizin Mainz.<b>S.\u00a0Becker<\/b>: Finanzielle Interessen: Ger\u00e4te und finanzielle Unterst\u00fctzung: Ambu \u2013 Honorare und Reisekostenerstattung: ALK Abell\u00f3, HAL, Allergopharma, Bencard Allergy, Ambu | Honorare: Thermo Fisher Scientific \u2013 Berater\/Schulungsreferent: Ambu | Berater: Bencard Allergy, Sanofi Genzyme, Bristol Meyer Squibb. Nichtfinanzielle Interessen: angestellter HNO-Arzt, HNO-Klinik Universit\u00e4tsmedizin Mainz und Universit\u00e4ts-HNO-Klinik T\u00fcbingen | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Hals-Chirurgie, \u00c4rzteverband Deutscher Allergologen (AEDA), Deutsche Gesellschaft f\u00fcr Allergologie und klinische Immunologie, European Academy of Allergy and Clinical Immunology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung aufExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}